BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Concord Biotech Ltd

Pharmaceuticals

Offer Period :

4th to 8th Aug 2023

Established in 1984, Concord Biotech Limited is a leading global biopharma company specializing in fermentation-based APIs for immunosuppressants and oncology. With a vast product range, it operates globally, supplying to 70+ countries. Read more... The company's growth encompasses API manufacturing, finished formulations, and a promising product pipeline.Read less

Concord Biotech Ltd IPO Details

IPO Date 4th to 8th Aug 2023 Minimum Investment ₹14820 / 1 Lots
Listing Date 2023-08-18 Maximum Investment ₹192660 / 13 Lots
Face Value ₹1 per share Total Issue Size ₹1475.26 Crores
Price ₹741 to ₹741 per share Fresh Issue ₹0 Crores
Lot Size 1 Lots (20 Shares) Offer For Sale ₹ 1475.26
Listing At BSE, NSE Retail Discount ₹ 0
Employee Discount ₹0 per share    
IPO Date 4th to 8th Aug 2023
Listing Date 2023-08-18
Face Value ₹1 per share
Price ₹741 to ₹741 per share
Lot Size 1 Lots (20 Shares)
Listing At BSE, NSE
Employee Discount ₹0 per share
Minimum Investment ₹14820 / 1 Lots
Maximum Investment ₹192660 / 13 Lots
Total Issue Size ₹1475.26 Crores
Fresh Issue ₹0 Crores
Offer For Sale
Retail Discount ₹ 0

Timeline

Important dates for allocation and IPO listing.

4th Aug

IPO Starts

8th Aug

IPO Ends

11th Aug

Allotment Date

14th Aug

Initiation of Refund

17th Aug

Credit of Shares to Demat Account

18th Aug

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 29.4 0
Public Group 70.6 0

Concord Biotech Ltd IPO Reservation

QIB Shares Offered 10457826(49.98%)
NII (HNI) Shares Offered 3137348(14.99%)
Retail Shares Offered 7320478(34.98%)
Anchor Investor Shares Offered 0(0%)
Total Shares Offered 20925652
Total Shares With Anchor Investor 20925652

IPO Lot Size

ApplicationLotsSharesAmount
Retail (Min)---
Retail (Max)---
S-HNI (Min)---
S-HNI (Max)---

Concord Biotech Ltd IPO Registrar

Link Intime India Pvt Ltd
Phone Number +91 810 811 4949
Email Id concordbiotech.ipo@linkintime.co.in
Our Website www.linkintime.co.in

Concord Biotech Ltd IPO Lead Manager

1. Kotak Mahindra Capital Company Ltd

2. Citigroup Global Markets India Pvt Ltd

3. Jeffries India Pvt Ltd

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Concord Biotech Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed

Strength of Concord Biotech Ltd

1. Established presence across the complex fermentation value chain;

2. Global leadership in immunosuppressant APIs along with a wide spectrum of complex fermentation-based APIs across multiple therapeutic areas;

3. Scaled manufacturing facilities with a consistent regulatory compliance track record and supported by strong R&D capabilities;

4. Diversified global customer base with long-standing relationships with key customers;

5. Experienced Promoters, management team supported by marquee investors;

6. Financial track record of rapid growth and consistent profitability with healthy cash flows and shareholder returns.

Risks Involved

1. Any delay, interruption or reduction in the supply of its raw materials or the transportation of the company raw materials or products may adversely impact the pricing and supply of its products and have an adverse effect on its business.

2. Any manufacturing or quality control issues may damage its reputation, subject it to regulatory action, and expose the company to litigation or other liabilities, which could adversely affect its business, financial condition and results of operations.

3. A slowdown or shutdown in its manufacturing or research and development operations, all located in Gujarat, India, could adversely affect the company business, financial condition and results of operations.

4. The company depends on a limited number of key customers for a substantial portion of its revenues. Any significant reduction in demand for the company products from such customers may adversely affect its business and results of operations.

5. If the company is unable to obtain trademarks and patents for its products or protect such proprietary information, or inadvertently infringe on the patents of others, its business may be adversely affected.

6. The company is subject to extensive government regulations, and if its fail to obtain, maintain or renew the company statutory and regulatory licenses, permits and approvals required for its business operations, the company business, financial condition, results of operations and cash flows may be adversely affected.

7. The company inability to accurately forecast demand for its products, manage it inventory and utilize the company manufacturing capacity optimally may have an adverse effect on its business, financial condition, results of operations and cash flows.

8. Pricing pressure from customers may affect the company ability to maintain or increase its product prices and, in turn, the company revenue from product sales, gross margin and profitability, which may adversely affect its business, financial condition and results of operations.

9. The company had significant working capital requirements. If its experience insufficient cash flows to fund the company working capital requirements, there may be an adverse effect on its business, cash flows and results of operations.

10. The company is currently entitled to certain incentive schemes. Any decrease in or discontinuation in such schemes may affect the company results of operations.

Why should you invest in

-

Financials

Particulars For the financial year ending (in ₹ million)
  2024 2023 2022
Total Assets 1700.71 1513.98 1312.79
Total Liabilities 1700.71 1513.98 1312.79
Total Expenses 641.53 568.42 495.19
Total Revenue 
1050.72 888.48 736.35
Profit After Tax 308.1 240.09 174.93
EBITDA 468.71 380.56 293.05
Adjusted EBITDA 0 0 0

Concord Biotech Ltd IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
2023-08-18 543960 CONCORDBIO
INE338H01029
₹741 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹741 ₹741
Open ₹900.05 ₹900.05
Low ₹900 ₹900.05
High ₹987.05 ₹987.7
Low ₹900 ₹900.05

Frequently Asked Questions

What is Concord Biotech Ltd IPO?

Answer Field

Concord Biotech Ltd IPO is a Mainboard IPO of 2,09,25,652 equity shares of a face value of ₹1 aggregating up to ₹1475.26 Crores. The issue is priced at ₹741 to ₹741 per share. The minimum order quantity is 20 Shares. The IPO opens on August 04, 2023, and closes on August 08, 2023. Link Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE,NSE.

When Concord Biotech Ltd IPO will open?

Answer Field

The Concord Biotech Ltd IPO opens on August 04, 2023 and closes on August 08, 2023.

What is the lot size of Concord Biotech Ltd?

Answer Field

Concord Biotech Ltd lot size is 20 shares, and the minimum amount required is ₹14,820.

How to apply for Concord Biotech Ltd IPO?

Answer Field

You can apply in Concord Biotech Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Concord Biotech Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Concord Biotech Ltd IPO will be done on August 11, 2023, and the allotted shares will be credited to your demat account by August 17, 2023.

When is Concord Biotech Ltd IPO listing date?

Answer Field

The Concord Biotech Ltd listing date is August 18, 2023.

Who is the registrar of Concord Biotech Ltd IPO?

Answer Field

The registrar of Concord Biotech Ltd IPO is Link Intime India Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Kotak Mahindra Capital Company Ltd,Citigroup Global Markets India Pvt Ltd,Jeffries India Pvt Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Concord Biotech Ltd IPO?

Answer Field

The fresh issue size is ₹[-] Crores equity shares.

What minimum lot size can retail subscribers subscribe to Concord Biotech Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 20 shares and ₹14,820 amount.

How can I approve the UPI mandate request for Concord Biotech Ltd IPO?

Answer Field

To apply for Concord Biotech Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Concord Biotech Ltd?

Answer Field

The price of each Concord Biotech Ltd share will be ranging in between ₹741 to ₹741 per share.

What is the cut-off time for the UPI mandate for Concord Biotech Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, August 08, 2023.

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • YASH HIGHVOLTAGE LIMITEDSME IPO

  • Bidding Dates

    12th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹138.0 - 146.0

  • IPO Size

    ₹1,10,01,00,000

  • Apply Now
  • HAMPS BIO LIMITEDSME IPO

  • Bidding Dates

    13th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹51.0 - 51.0

  • IPO Size

    ₹6,22,00,000

  • Apply Now
  • NACDAC INFRASTRUCTURE LIMITEDSME IPO Early Access

  • Bidding Dates

    17th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹33.0 - 35.0

  • IPO Size

    ₹10,01,00,000

  • Apply Now
  • NACDAC INFRASTRUCTURE LIMITEDSME IPO Early Access

  • Bidding Dates

    17th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹33.0 - 35.0

  • IPO Size

    ₹10,01,00,000

  • Apply Now
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • SWIGGY LIMITEDMainboard IPO

  • Bidding Dates

    6th Nov 2024 - 11th Nov 2024

  • Price Range

    ₹371.0 - 390.0

  • IPO Size

    ₹1,13,27,43,00,000

  • Invest Now
performance-radio
  • IPO Name
  • ISSUE PRICE
  • LISTING DAY CLOSE
  • LISTING DAY(GAIN/LOSS)
  • Lorem Ipsum
  • ONYX BIOTEC LIMITEDSME IPO

  • Issue Price

    61.00

  • Listing Day Close

    56.75

  • Listing Day (Gain/Loss)

    -6.56

  • SWIGGY LIMITEDMainboard IPO

  • Issue Price

    390.00

  • Listing Day Close

    455.95

  • Listing Day (Gain/Loss)

    16.92

  • DANISH POWER LIMITEDSME IPO

  • Issue Price

    380.00

  • Listing Day Close

    598.50

  • Listing Day (Gain/Loss)

    57.63

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text